eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Abstracting and indexing Subscription Contact Instructions for authors
4/2017
vol. 9
 
Share:
Share:
more
 
 
abstract:
Original paper

Efficacy of oxycodone in sustained-release, divisible tablet in the therapy of pain prescribed by palliative medicine physicians and oncologists in daily clinical practice

Jerzy Chudek, Grzegorz Orlik, Iga Grochoła, Agnieszka Almgren-Rachtan

Medycyna Paliatywna 2017; 9(4): 218–224
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
The aim of the study
This study aims to evaluate the efficacy of oxycodone sustained-release, divisible tablets in pain treatment in daily clinical practice.

Material and methods
Seventy-four oncologists and 34 palliative medicine physicians surveyed 1760 outpatients with pain of different aetiologies, persisting in 1198 for more than three months, treated with oxycodone sustained-release divisible tablets over three consecutive visits. Analgesic efficacy and the effect of pain on daily activities were measured using visual analogue scales. Suitability of oxycodone tablet splitting was assessed with a four-point scale.

Results
Oxycodone sustained-release, divisible tablets were mainly used for cancer pain treatment (95.7%). Higher drug doses were recommended by palliative medicine physicians than by oncologists at baseline (47.5 ±43.7 mg vs. 43.8 ±32.6 mg; p < 0.001) and at the end of follow-up (60.9 ±53.4 mg vs. 53.1 ±38.9 mg; p < 0.001). At the beginning of follow-up, the severity of pain was comparable in patients treated by oncologists and palliative medicine physicians. During 64 ±28 days of follow-up, the efficacy of analgesic therapy increased slightly more among patients treated by palliative medicine physicians and was associated with a significantly reduced effect of pain on patients’ daily activities. The percentage of palliative medicine physicians (and their patients) who appreciated the advantage of oxycodone tablet splitting at dosage adjustment increased during follow-up. At its end, over 70% of palliative medicine physicians and oncologists, and their patients, appreciated this advantage.

Conclusions
Palliative medicine physicians obtain greater analgesic efficacy of oxycodone sustained-release tablets in the therapy of pain than oncologists. Oxycodone sustained-release tablet splitting for dose adjustment is appreciated by the majority of physicians and their patients.

keywords:

oxycodone, chronic pain, cancer pain, divisibility of the tablet

Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe